Jeroen Bekaert is the founder of Orca Bio. Orca Bio has raised $300M in total funding. Latest round: Series D. Based in Menlo Park, CA, United States.
Jeroen Bekaert is a co-founder and President of Orca Bio, a clinical-stage biotechnology company developing high-precision allogeneic cell therapies to transform the lives of patients with high-risk blood cancers. The company has raised nearly $300 million in total capital since its launch in 2016. Before co-founding Orca Bio, Bekaert led Merck KGaA’s innovation center in Silicon Valley and held various positions at Johnson & Johnson’s Supply Chain group.
Full founder directory · Investor directory · Company funding database · Fundraising library